ScopeMedizinisches Versorgungszentrum an der Universitätsmedizin Greifswald GmbH MVZ Hans-Beimler-Straße, Bereich Humangenetik
19 capabilities
Accredited since July 2025
Verified Apr 2026
One of 3,039 in Germany
Details
Fleischmannstraße 43
Greifswald 17475 , Germany
Greifswald 17475 , Germany
Accreditation
Active
DAkkS
D-ML-22497-01-00
Specialises in molecular human genetics testing using Sanger sequencing, PCR, and MLPA techniques to identify genetic variants associated with familial adenomatous polyposis and gastrointestinal polyposis syndromes from blood and DNA samples.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-22497-01-00
Status
ActiveSince
11 July 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (19)
| Standard Reference | Description | Category |
|---|---|---|
| (APC, MUTYH) | (APC, MUTYH) | Molecular Diagnostics / PCR |
| (BRCA1, BRCA2) | Inhibitor Therapie (BRCA1, BRCA2) | Molecular Diagnostics / PCR |
| (CDH1, CHEK2, PALB2, RAD51C, RAD51D) | (CDH1, CHEK2, PALB2, RAD51C, RAD51D) | Molecular Diagnostics / PCR |
| (MLH1/MSH2, MSH6, PMS2) | (MLH1/MSH2, MSH6, PMS2) | Molecular Diagnostics / PCR |
| Adenomatöse Polyposis | Familiäre Adenomatöse Polyposis | Molecular Diagnostics / PCR |
| Brust- und Eierstockkrebs | Familiärer Brust- und Eierstockkrebs | Molecular Diagnostics / PCR |
| Familiäre Polyposis-Syndrome [FAP] | Familiäre Polyposis-Syndrome [FAP] | Molecular Diagnostics / PCR |
| Familiärer Brust- und | Familiärer Brust- und | Molecular Diagnostics / PCR |
| Familiäres Pankreaskarzinom [FPC] | Familiäres Pankreaskarzinom [FPC] | Molecular Diagnostics / PCR |
| Kolorektales Karzinom | Kolorektales Karzinom | Molecular Diagnostics / PCR |
| Kolorektales Karzinom [HNPCC | Kolorektales Karzinom [HNPCC | Molecular Diagnostics / PCR |
| Ovarialkarzinom (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, RAD51C, RAD51D, TP53) | Ovarialkarzinom (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, RAD51C, RAD51D, TP53) | Molecular Diagnostics / PCR |
| Syndrome (APC, MUTYH) | Syndrome (APC, MUTYH) | Molecular Diagnostics / PCR |
| (ATM , BARD1 , BRCA1 , BRCA2 | (ATM , BARD1 , BRCA1 , BRCA2 | Other |
| (BRCA2 , CDKN2A , PALB2 , STK11 | (BRCA2 , CDKN2A , PALB2 , STK11 | Other |
| Lynch-Syndrom] (MLH1 , MSH2 | Lynch-Syndrom] (MLH1 , MSH2 | Other |
| MSH6 , PMS2 ), TruRisk® -Panel [SNV, CNV] | MSH6 , PMS2 ), TruRisk® -Panel [SNV, CNV] | Other |
| STK11, SMAD4 ), TruRisk® -Panel [SNV, CNV] | STK11, SMAD4 ), TruRisk® -Panel [SNV, CNV] | Other |
| TP53 ), TruRisk® -Panel [SNV, CNV] | TP53 ), TruRisk® -Panel [SNV, CNV] | Other |